《Table 1 Stratified analysis of recurrence-free survival in The Cancer Genome Atlas cohort》

《Table 1 Stratified analysis of recurrence-free survival in The Cancer Genome Atlas cohort》   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
a Statistically significant.BMI:Body mass index;ECOG:Eastern Cooperative Oncology Group;HBV:Hepatitis B virus;HCV:Hepatitis C virus.

Stratified survival analysis in the validation series was conducted to further investigate the suitable patient group of the six-lncRNA signature.The cut-off value in the subgroups was consistent with that in the overall group(0.0357).The result of stratification analysis was shown in Table 1.Our risk score system was more applicable to the patients possessing the following characteristics:TNM stage I/II,male gender,younger than 60 years,Asian,with family history,hepatitis B virus(HBV)infection,alcohol consumption,ECOG=0,and higher levels of preoperative serum albumin(ALB,>3,5g/dl)and alpha-fetoprotein(AFP,>20 ng/ml).